Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™
Samsung Biologics
Oct 10, 2025
PR-10-25-NI-11
Press Releases
Biologics - Large Molecule
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
Related Content
AI-Optimized CLD
From Screening to Design: Can Production Cell Lines Become Programmable Platforms?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-19
Jul 20, 2026
Drug–Device
Designing Formulations Around Devices Rather Than Vice Versa
Pharma's Almanac
PAO-07-26-PA-04
Jul 7, 2026
Protein Conformation
Designing Drugs Against Moving Proteins: Drug Discovery Enters the Era of Protein Conformational Ensembles
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-17
Jul 6, 2026
Bioavailability
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
AustinPx
PR-06-26-03
Jun 30, 2026
Research Collab
10x Genomics and Cleveland Clinic Collaborate in Diagnostic Applications of Single Cell and Spatial Technologies in Bladder Cancer
10x Genomics
PR-06-26-02
Jun 17, 2026
CNS Clinical
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969
Insilico Medicine
PR-06-26-01
Jun 17, 2026
Cell-Free Synthesis
Cell-Free Biomanufacturing and the Future of Flexible Biologics Production
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-24
Jun 15, 2026
Digital Sampling
Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling
Jiwoon Kim; Neulbit Kim; Hyeonjung Park
Samsung Biologics
PAO-06-26-CL-01
Jun 10, 2026
Protein Engineering
Exponential Advances in Protein Engineering
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-26-PA-04
Jun 8, 2026
BsAbs
Why Bispecific Antibody Architecture Is a CMC Decision
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-01
Jun 2, 2026
NGIB
Rethinking Fermentation: Halophiles and the Next Generation of Industrial Biotechnology
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-05
May 18, 2026
Partnership
The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation
The Solubility Company
PR-05-26-02
May 13, 2026
Previous slide
Next slide
